4//SEC Filing
Happel David 4
Accession 0001104659-25-070017
CIK 0001400118other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:16 PM ET
Size
5.0 KB
Accession
0001104659-25-070017
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Sale
Series A Common Stock
2025-07-21$9.13/sh−65,478$598,115→ 689,722 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001623567
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:16 PM ET
- Size
- 5.0 KB